News
Apple didn’t respond to Bloomberg’s request for comment. - Eli Lilly (LLY) are up in after hours trading. Earlier today, President Donald Trump said he plans to slash drug prices for Americans ...
Veteran cornerback Eli Apple seems to be the most impressed with Herbert's arm strength. Apple sees it at every practice when trying to cover his receivers which is always a challenge as Herbert ...
The Saints had a rough ending with Eli Apple, however, the former cornerback spoke fondly of his time in New Orleans in a recent interview with ReadWrite's Kyle Odegard. Apple was drafted to the ...
Trying to make a payment using your iPhone? You might need to use a third-party service, as Apple Cash appears to be down, and Apple Pay looks to be struggling too. Update: Apple’s system status ...
Matthew Herper covers medical innovation — both its promise and its perils. A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap ...
Eli Lilly said its Zepbound obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs ...
U.K.-based biotech Alchemab on Tuesday announced a licensing agreement with Eli Lilly (NYSE:LLY) to jointly develop ATLX-1282, an early-stage therapeutic candidate targeting amyotrophic lateral ...
While many pharma and biotech companies developing drugs to treat Alzheimer's disease are targeting amyloid beta plaque, Eli Lilly (NYSE:LLY) is looking at other targets as well. The drugmaker's ...
Apple acquired Canadian startup Mayday Labs in April 2024, according to a European Commission listing, spotted by French blog MacGeneration. The acquisition had not received widespread attention ...
Apple is looking at reworking Safari to directly support AI-powered search services, Bloomberg's Mark Gurman reports. Apple's senior vice president of services Eddy Cue today disclosed that Apple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results